Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Kogure, T., Kinghorn, A. D., Yan, I., Bolon, B., Lucas, D. M., Grever, M. R., & Patel, T. (2013).
PloS One, 8(9), e76136. doi:10.1371/journal.pone.0076136. eCollection 2013
Targeted cancer therapy: what if the driver is just a messenger?
Schatz, J. H., & Wendel, H.-G. (2011).
Cell Cycle (Georgetown, Tex.), 10(22), 3830–3. doi:10.4161/cc.10.22.18288. Epub 2011 Nov 15.
The relevance of higher plants in lead compound discovery programs.
Kinghorn, a D., Pan, L., Fletcher, J. N., & Chai, H. (2011).
Journal of Natural Products, 74(6), 1539–55. doi:10.1021/np200391c. Review
Potential of plant-derived natural products in the treatment of leukemia and lymphoma.
Lucas, D. M., Still, P. C., Pérez, L. B., Grever, M. R., & Kinghorn, A. D. (2010).
Current Drug Targets, 11(7), 812–22. Review.
Silvestrol: An emerging compound for cancer therapy.
Yeo, T.C.
Biodiversity-Biotechnology: Gateway to Discoveries, Sustainable Utilization and Wealth Creation, Manurung, R., Zaliha, C.A., Fasihuddin, B.A. and Kuek, C. (Eds), 19-21 November 2008, Kuching, Sarawak, Malaysia. pp229-33.
For purchase of silvestrol as reagent for studying molecular pathways, please contact us through the following form:
